Carrick Therapeutics

Carrick Therapeutics is at the forefront of biotechnology research, dedicated to pioneering a portfolio of unique, first-in-class cancer treatments. Focusing on the driver mechanisms of the most aggressive forms of cancer, Carrick Therapeutics is committed to developing therapies tailored to an individual patient’s tumor.

With a vision to transform cancer treatment, Carrick Therapeutics targets the molecular pathways that drive aggressive and resistant cancers. By linking a network of clinicians and scientists in internationally leading research institutes and hospitals, Carrick Therapeutics streamlines the introduction of ground-breaking cancer therapies into the clinic, serving cancer patients worldwide.

Carrick Therapeutics has its primary address at The Tower, Pearse Street, Dublin, IE and an additional location at Robert Robinson Avenue, The Oxford Science Park, Oxford, OX4 4GA, GB. We invite the manager of Carrick Therapeutics to create a customized and exclusive company showcase and product listing on our platform. Information will be completed soon with the support of the company’s management.